InsidersTradesSigma
Discover the full record of transactions filed by Orlinger Klaus, Vice-Président Exécutif, Recherche. Director active across 1 companies, notably HOOKIPA Pharma Inc.. In total, 2 disclosures have been published. The latest transaction was filed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Orlinger Klaus is Executive Vice President of Research at Hookipa Pharma Inc. In this role, he oversees the company's research and development operations. His expertise in the pharmaceutical sector enables him to effectively lead research and innovation teams. He plays a key role in developing new products and guiding Hookipa Pharma's strategic direction.